INAB

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 6

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2028-12-13

F4 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 5

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2028-12-13

F4 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F3 · price: The reported securities are included within 12,295 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 3

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2025-05-02

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012289 · form4-05072025_080507.xml · derivative · entry 2

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2025-10-04

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F3 · price: The reported securities are included within 12,295 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 12,295 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012287 · form4-05072025_080503.xml · derivative · entry 9

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,459

Underlying: Common Stock · 91,459 shares

Expires 2028-12-13

F5 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share and expiration date of December 13, 2028. In regards to 11,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. In regards to the remaining 91,459 warrant shares, the exercise price was reduced to $0.45 per share with no change to the expiration date.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012287 · form4-05072025_080503.xml · derivative · entry 7

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires 2025-05-02

F4 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share and expiration date of December 13, 2028. In regards to 11,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. In regards to the remaining 91,459 warrant shares, the exercise price was reduced to $0.45 per share with no change to the expiration date.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share and expiration date of December 13, 2028. In regards to 11,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. In regards to the remaining 91,459 warrant shares, the exercise price was reduced to $0.45 per share with no change to the expiration date.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012287 · form4-05072025_080503.xml · derivative · entry 6

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,459 shares

Expires 2028-12-13

F4 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share and expiration date of December 13, 2028. In regards to 11,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. In regards to the remaining 91,459 warrant shares, the exercise price was reduced to $0.45 per share with no change to the expiration date.

F3 · price: The reported securities are included within 102,459 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.

F4 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share and expiration date of December 13, 2028. In regards to 11,000 warrant shares, the exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025. In regards to the remaining 91,459 warrant shares, the exercise price was reduced to $0.45 per share with no change to the expiration date.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012287 · form4-05072025_080503.xml · derivative · entry 4

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,459

Underlying: Common Stock · 102,459 shares

Expires 2025-05-02

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012287 · form4-05072025_080503.xml · derivative · entry 3

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,459 shares

Expires 2025-10-04

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F3 · price: The reported securities are included within 102,459 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012286 · form4-05072025_080501.xml · derivative · entry 8

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,967

Underlying: Common Stock · 81,967 shares

Expires 2025-05-02

F5 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and expiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F5 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and expiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012286 · form4-05072025_080501.xml · derivative · entry 7

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81,967 shares

Expires 2028-12-13

F5 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and expiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F4 · price: The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

F5 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 and expiration date of December 13, 2028. The exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012286 · form4-05072025_080501.xml · derivative · entry 5

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,967

Underlying: Common Stock · 81,967 shares

Expires 2025-05-02

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012286 · form4-05072025_080501.xml · derivative · entry 4

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81,967 shares

Expires 2025-10-04

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 and later amended on October 4, 2024 with an exercise price of $0.45 per share and expiration date of October 4, 2025. On April 27, 2025, the warrant's exercise price was reduced to $0.1844 per share and the warrant expiration date was amended to May 2, 2025.

F4 · price: The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012293 · form4-05072025_080516.xml · derivative · entry 2

Lamb Lawrence · CIK 0001830059 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,639

Underlying: Common Stock · 1,639 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012293 · form4-05072025_080516.xml · derivative · entry 1

Lamb Lawrence · CIK 0001830059 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,639 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F3 · price: The reported securities are included within 1,639 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 1,639 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012292 · form4-05072025_080513.xml · derivative · entry 2

Graff Jeremy R. · CIK 0001975028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,049

Underlying: Common Stock · 2,049 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012292 · form4-05072025_080513.xml · derivative · entry 1

Graff Jeremy R. · CIK 0001975028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,049 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F3 · price: The reported securities are included within 2,049 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 2,049 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012291 · form4-05072025_080511.xml · derivative · entry 2

Epperly Corinne · CIK 0001839156 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,967

Underlying: Common Stock · 81,967 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012291 · form4-05072025_080511.xml · derivative · entry 1

Epperly Corinne · CIK 0001839156 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81,967 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F3 · price: The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per unit. Each unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012290 · form4-05072025_080509.xml · derivative · entry 2

Ho William Tai-Wei · CIK 0001830914 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,967

Underlying: Common Stock · 81,967 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-012290 · form4-05072025_080509.xml · derivative · entry 1

Ho William Tai-Wei · CIK 0001830914 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 81,967 shares

Expires 2028-12-13

F1 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F1 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.50 per share. The exercise price was reduced to $0.45 per share.

F3 · price: The reported securities are included within 81,967 units purchased by the Reporting Person on December 13, 2023 for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

F2 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-25-003346 · form4-02072025_040211.xml · derivative · entry 1

McCall Patrick · CIK 0001874384 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,000

Underlying: Common Stock · 343,000 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001415889-25-003344 · form4-02072025_040206.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,950

Underlying: Common Stock · 338,950 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001415889-25-003343 · form4-02072025_040203.xml · derivative · entry 1

Ho William Tai-Wei · CIK 0001830914 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 912,450

Underlying: Common Stock · 912,450 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001415889-25-003345 · form4-02072025_040208.xml · derivative · entry 1

Lamb Lawrence · CIK 0001830059 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 306,750

Underlying: Common Stock · 306,750 shares

Expires 2035-02-05

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option shall vest on February 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

SEC source: 0001415889-24-030059 · form4-12232024_041209.xml · derivative · entry 1

McCall Patrick · CIK 0001874384 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,085

Underlying: Common Stock · 290,085 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030057 · form4-12232024_041205.xml · derivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,839

Underlying: Common Stock · 302,839 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030064 · form4-12232024_041218.xml · derivative · entry 1

Greenwood Luba · CIK 0001853815 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,449

Underlying: Common Stock · 39,449 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030060 · form4-12232024_041211.xml · derivative · entry 1

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,242

Underlying: Common Stock · 93,242 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030061 · form4-12232024_041213.xml · derivative · entry 1

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,490

Underlying: Common Stock · 49,490 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030063 · form4-12232024_041216.xml · derivative · entry 1

FAIRBAIRN EMILY · CIK 0001682638 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,559

Underlying: Common Stock · 31,559 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030065 · form4-12232024_041220.xml · derivative · entry 1

Graff Jeremy R. · CIK 0001975028 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,697

Underlying: Common Stock · 47,697 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030066 · form4-12232024_041222.xml · derivative · entry 1

Epperly Corinne · CIK 0001839156 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,655

Underlying: Common Stock · 37,655 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030062 · form4-12232024_041215.xml · derivative · entry 1

Whitfill Travis · CIK 0001830178 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,676

Underlying: Common Stock · 42,676 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030058 · form4-12232024_041207.xml · derivative · entry 1

Lamb Lawrence · CIK 0001830059 · EVP and CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 286,899

Underlying: Common Stock · 286,899 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-030056 · form4-12232024_041204.xml · derivative · entry 1

Ho William Tai-Wei · CIK 0001830914 · Director · PRESIDENT AND CEO · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,188,282

Underlying: Common Stock · 1,188,282 shares

Expires 2034-12-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on December 19, 2025, subject to the Reporting Person continuing to provide service on such date.

SEC source: 0001415889-24-024869 · form4-10082024_041008.xml · derivative · entry 4

McCall Patrick · CIK 0001874384 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,316

Underlying: Common Stock · 25,316 shares

Expires 2027-10-04

F1 · price: The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024869 · form4-10082024_041008.xml · derivative · entry 3

McCall Patrick · CIK 0001874384 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,492

Underlying: Common Stock · 20,492 shares

Expires 2025-10-04

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024869 · form4-10082024_041008.xml · derivative · entry 2

McCall Patrick · CIK 0001874384 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,492 shares

Expires 2025-06-13

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024869 · form4-10082024_041008.xml · nonDerivative · entry 1

McCall Patrick · CIK 0001874384 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,071

F1 · price: The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · derivative · entry 4

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,316

Underlying: Common Stock · 25,316 shares

Expires 2027-10-04

F1 · price: The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · derivative · entry 3

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,295

Underlying: Common Stock · 12,295 shares

Expires 2025-10-04

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · derivative · entry 2

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,295 shares

Expires 2025-06-13

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 12,295 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024871 · form4-10082024_041010.xml · nonDerivative · entry 1

Rochlin Kate · CIK 0001898521 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,874

F1 · price: The reported securities are included within 25,316 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 25,316 shares of common stock.

SEC source: 0001415889-24-024868 · form4-10082024_041006.xml · derivative · entry 4

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,582

Underlying: Common Stock · 126,582 shares

Expires 2027-10-04

F1 · price: The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024868 · form4-10082024_041006.xml · derivative · entry 3

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,459

Underlying: Common Stock · 102,459 shares

Expires 2025-10-04

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 102,459 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024868 · form4-10082024_041006.xml · derivative · entry 2

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 102,459 shares

Expires 2025-06-13

F2 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F2 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F4 · price: The reported securities are included within 102,459 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 102,459 shares of common stock.

F3 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024868 · form4-10082024_041006.xml · nonDerivative · entry 1

Roemer Alan S. · CIK 0001643070 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,030

F1 · price: The reported securities are included within 126,582 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 126,582 shares of common stock.

SEC source: 0001415889-24-024867 · form4-10082024_041004.xml · derivative · entry 5

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,164

Underlying: Common Stock · 253,164 shares

Expires 2027-10-04

F1 · price: The reported securities are included within 253,164 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 253,164 shares of common stock.

F4 · derivative.exercise_date: Fully vested and exercisable.

SEC source: 0001415889-24-024867 · form4-10082024_041004.xml · derivative · entry 4

Brandt Peter C. · CIK 0001434099 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,967

Underlying: Common Stock · 81,967 shares

Expires 2025-10-04

F3 · kind: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F3 · price: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.

F5 · price: The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.

F4 · derivative.exercise_date: Fully vested and exercisable.